ARRB1 Protein — Arrestin Beta 1

ARRB1 Protein (Arrestin Beta 1)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ARRB1 Protein — Arrestin Beta 1</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Arrestin Beta 1 (ARRB1, β-arrestin 1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ARRB1](/genes/arrb1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P49407</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>46 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>418</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, plasma membrane, nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Arrestin family (visual arrestin, β-arrestin 1, β-arrestin 2)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>

Overview

ARRB1 Protein (Arrestin Beta 1)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ARRB1 Protein — Arrestin Beta 1</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Arrestin Beta 1 (ARRB1, β-arrestin 1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[ARRB1](/genes/arrb1)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P49407</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>46 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>418</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, plasma membrane, nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Arrestin family (visual arrestin, β-arrestin 1, β-arrestin 2)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">15 edges</a></td>
</tr>
</table>

Overview

ARRB1 (Arrestin Beta 1), also known as beta-arrestin 1, is a multifunctional scaffolding protein that plays critical roles in regulating G protein-coupled receptor (GPCR) signaling, clathrin-mediated endocytosis, and various cellular signaling cascades. Originally characterized as a terminator of GPCR signaling, ARRB1 has emerged as a versatile signaling platform with important implications for neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease)[@lefkowitz2013][@lutz2014].

ARRB1 is encoded by the ARRB1 gene and is expressed widely in the central nervous system, particularly in neurons of the hippocampus, cortex, and basal ganglia. The protein localizes to both the cytoplasm and plasma membrane, enabling its dual roles in receptor desensitization and signaling scaffold formation.

Structure and Molecular Characteristics

ARRB1 is a 418-amino acid protein with a molecular weight of approximately 46 kDa. The protein adopts a characteristic arrestin fold with two domains connected by a flexible hinge region.

Domain Architecture

• N-terminal domain: Contains the receptor recognition interface
• C-terminal domain: Mediates interactions with clathrin and adaptor proteins
• Hinge region: Enables conformational changes required for signaling
• Nuclear localization signals: Enable ARRB1 to translocate to the nucleus

Normal Physiological Function

Under normal physiological conditions, ARRB1 performs essential functions in cellular signaling:

GPCR Desensitization and Internalization

ARRB1's classical function involves binding to phosphorylated GPCRs[@lefkowitz2013]:

• Binds to active, phosphorylated GPCRs in the cytosolic loop regions
• Prevents further G protein coupling (desensitization)
• Blocks receptor activation even in the presence of agonist
• Promotes receptor internalization via clathrin-coated pits
• Targets receptors for either recycling or degradation

Signaling Scaffold Function

Beyond desensitization, ARRB1 serves as a signaling scaffold:

• MAPK pathway activation: Recruits Raf, MEK, and ERK to receptor complexes
• PI3K/Akt signaling: Facilitates Akt phosphorylation and signaling
• Src family kinases: Activates Src family kinases for downstream effects
• NF-κB signaling: Modulates inflammatory gene expression

Clathrin-Mediated Endocytosis

ARRB1 contains clathrin-binding motifs that enable:

• Recruitment of clathrin triskelions to receptor-containing membrane domains
• Interaction with AP-2 adaptor protein complexes
• Formation of clathrin-coated vesicles
• Cargo selection and packaging

Nuclear Signaling

ARRB1 translocates to the nucleus where it:

• Modulates gene transcription
• Interacts with transcription factors
• Regulates chromatin remodeling complexes

Role in Neurodegenerative Diseases

Alzheimer's Disease

ARRB1 is implicated in multiple aspects of Alzheimer's disease pathogenesis[@yang2017]:

Tau Pathology: ARRB1 modulates tau phosphorylation and aggregation[@chen2019]. Studies show that ARRB1 interacts with tau kinases and affects tau clearance pathways. Altered ARRB1 function contributes to neurofibrillary tangle formation.

Amyloid-beta Handling: ARRB1 participates in amyloid-beta clearance through[@xu2019]:

• Regulating amyloid precursor protein (APP) processing
• Modulating amyloid-beta uptake and degradation
• Influencing microglial phagocytosis

GPCR Signaling Dysregulation: Many GPCRs implicated in Alzheimer's show altered ARRB1-dependent signaling:

• Muscarinic acetylcholine receptors
• Serotonin receptors
• Glutamate receptors including [NMDA receptors](/entities/nmda-receptor)

Parkinson's Disease

In Parkinson's disease, ARRB1 plays crucial roles in dopaminergic signaling[@liu2020]:

Dopamine Receptor Signaling: ARRB1 regulates dopamine D1 and D2 receptor signaling:

• Controls receptor desensitization and internalization
• Modulates striatal signaling pathways
• Affects motor control and reward processing

• May influence Lewy body formation
• Regulates autophagy of α-synuclein species
• Modulates cellular vulnerability to α-synuclein toxicity

• Regulates mitophagy pathways
• Affects mitochondrial dynamics
• Influences neuronal survival

Genetic Associations

Studies have identified ARRB1 variants associated with neurodegenerative diseases[@ma2020]:

• Specific ARRB1 SNPs modify Parkinson's disease risk
• Rare variants may alter receptor signaling dynamics
• Genetic associations highlight ARRB1's importance in disease pathogenesis

Therapeutic Targeting

ARRB1 represents a promising therapeutic target for neurodegenerative diseases:

Biased Ligand Development

Biased agonists that promote beneficial ARRB1 signaling are under development[@tang2021]:

• D2R-biased ligands: Prefer β-arrestin signaling over G protein signaling
• mGluR5 biased ligands: Reduce β-arrestin-dependent pathological signaling
• 5-HT2C biased ligands: Therapeutic potential in neuropsychiatric symptoms

Small Molecule Inhibitors

Targeting ARRB1 interactions[@xu2022]:

• ARRB1-REC inhibitors: Block receptor-ARRB1 interactions
• Signal pathway inhibitors: Selective targeting of ARRB1-mediated signaling
• Nuclear import inhibitors: Prevent ARRB1 nuclear translocation

Gene Therapy Approaches

Viral vector-mediated modulation:

• AAV-delivered ARRB1 shRNA for knockdown
• CRISPR-based editing of ARRB1 regulatory regions
• Overexpression of engineered ARRB1 variants

Research Highlights

Key findings from recent ARRB1 research:

Interaction Network

Animal Models

Several animal models have been developed to study ARRB1 function:

• ARRB1 knockout mice: Viable but show altered GPCR signaling
• Neuron-specific knockouts: Enable study of CNS-specific functions
• Conditional models: Allow temporal control of ARRB1 deletion
• Transgenic models: Overexpress wild-type or mutant ARRB1

Clinical Relevance

Biomarker Potential

ARRB1 may serve as a biomarker:

• Blood ARRB1 levels correlate with disease severity
• CSF ARRB1 in neurodegenerative disease patients
• Peripheral monocyte ARRB1 as surrogate marker

Therapeutic Implications

Challenges in targeting ARRB1:

• Selectivity: Distinguishing ARRB1 from ARRB2 functions
• Cell-type specificity: CNS versus peripheral effects
• Biphasic effects: Both too much and too little ARRB1 may be harmful

Future Directions

Key research directions for ARRB1:

See Also

• [ARRB1 Gene](/genes/arrb1)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [G Protein-Coupled Receptor Signaling](/mechanisms/g-protein-coupled-receptor-signaling)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Tau Protein](/proteins/tau)
• [NMDA Receptor](/entities/nmda-receptor)
• [NF-κB Signaling](/entities/nf-kb)
• [Clathrin-Mediated Endocytosis](/entities/clathrin)

References